Authors

  1. Kletzel, Sandra L. PhD
  2. Aaronson, Alexandra L. MD
  3. Guernon, Ann PhD
  4. Carbone, Christina PsyD
  5. Chaudhry, Noor
  6. Walsh, Elyse DPT
  7. Conneely, Mark MD
  8. Patil, Vijaya MD
  9. Roth, Elliott MD
  10. Steiner, Monica MD
  11. Pacheco, Marilyn MD
  12. Rosenow, Joshua MD, FACS
  13. Bender Pape, Theresa L. DrPH, MA, CCC-SLP/L

Abstract

Objective: For persons in states of disordered consciousness (DoC) after severe traumatic brain injury (sTBI), we report cumulative findings from safety examinations, including serious adverse events (AEs) of a repetitive transcranial magnetic stimulation (rTMS) parameter protocol in 2 different studies.

 

Participants: Seven persons in states of DoC after sTBI with widespread neuropathology, but no large lesions in proximity to the site of rTMS. One participant had a ventriculoperitoneal shunt with programmable valve.

 

Methods: Two clinical trials each providing 30 rTMS sessions to the right or left dorsolateral prefrontal cortex, involving 300 to 600 pulses over 1 or 2 sessions daily. One study provided concomitant amantadine. Safety indicators monitored related to sleep, temperature, blood pressure, skin integrity, sweating, weight loss, infections, and seizure.

 

Results: Average changes for monitored indicators were of mild severity, with 75 nonserious AEs and 1 serious AE (seizure). The participant incurring a seizure resumed rTMS while taking antieplieptics without further seizure activity.

 

Conclusions: Considering elevated risks for this patient population and conservative patient selection, findings indicate a relatively safe profile for the specified rTMS protocols; however, potential for seizure induction must be monitored. Future research for this population can be broadened to include patients previously excluded on the basis of profiles raising safety concerns.